The application and outlook of proteomics in Ovarian Cancer, Breast Cancer, and Colon Cancer

Author:

Xie Yiru

Abstract

Cancer, a pervasive challenge of global health, necessitates advanced technologies for diagnosticsand therapies. Ovarian, breast, and colon cancers, notable for their complexity, have made significantdiscoveries with the help of proteomics. Ovarian cancer, diagnosed late, benefits from proteomicsbiomarkers like CA-125 and plasma CRP, offering early detection and insights into sub-types. Breast cancerleverages proteomics for sub-type classification, treatment prediction, and liquid biopsy development.Markers like uPA and PAI-1 guide therapies, while phosphorous proteomics unveils crucial signalingpathways. Colon cancer, marked by its prevalence, sees proteomics aiding biomarker discovery, sub-typeclassification, and predicting treatment responses, fostering personalized treatments. Liquid biopsydevelopment holds promise for real-time monitoring. Propelled by advanced technologies like LC-MS/MSand iTRAQ, proteomics provides a holistic view of cancer biology. Integrating with genomics refinesprecision medicine. Insights from proteomics in ovarian, breast, and colon cancers mark a era oftransformation, offering personalized cancer care and improved clinical outcomes.

Publisher

EDP Sciences

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3